Figure 7From: Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy AgencyLocal recurrence free survival by age. Improved RFS for patients younger than 40 years (p = 0.058).Back to article page